Tango Therapeutics (TNGX) Accumulated Depreciation & Amortization (2020 - 2025)
Tango Therapeutics (TNGX) has 6 years of Accumulated Depreciation & Amortization data on record, last reported at $10.5 million in Q4 2025.
- For Q4 2025, Accumulated Depreciation & Amortization rose 26.01% year-over-year to $10.5 million; the TTM value through Dec 2025 reached $10.5 million, up 26.01%, while the annual FY2025 figure was $10.5 million, 26.01% up from the prior year.
- Accumulated Depreciation & Amortization reached $10.5 million in Q4 2025 per TNGX's latest filing, up from $8.4 million in the prior quarter.
- Across five years, Accumulated Depreciation & Amortization topped out at $10.5 million in Q4 2025 and bottomed at $2.5 million in Q4 2021.
- Average Accumulated Depreciation & Amortization over 5 years is $5.7 million, with a median of $5.1 million recorded in 2023.
- Peak YoY movement for Accumulated Depreciation & Amortization: surged 62.7% in 2023, then rose 26.01% in 2025.
- A 5-year view of Accumulated Depreciation & Amortization shows it stood at $2.5 million in 2021, then skyrocketed by 45.55% to $3.7 million in 2022, then soared by 62.7% to $6.0 million in 2023, then soared by 39.64% to $8.4 million in 2024, then grew by 26.01% to $10.5 million in 2025.
- Per Business Quant database, its latest 3 readings for Accumulated Depreciation & Amortization were $10.5 million in Q4 2025, $8.4 million in Q4 2024, and $7.7 million in Q3 2024.